Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Advinus Therapeutics discloses novel glucokinase activators

Aug. 23, 2011

SRT-1720 has beneficial effects in obesity model

Aug. 23, 2011

Santarus and Depomed enter new U.S. commercialization agreement for Glumetza

Aug. 22, 2011

Mochida signs agreement with Ajinomoto to take over Japanese distribution of Fastic

Aug. 22, 2011

Phase II trial of Diabecell begins in Argentina in patients with type 1 diabetes

Aug. 22, 2011

Japanese scientists present novel series of ASK-1 inhibitors

Aug. 22, 2011

Hydrogen sulfide replacement may protect against complications of diabetes

Aug. 19, 2011

Afexa Life Sciences reports on LIP-01 trial in cholesterol management

Aug. 19, 2011

Ranbaxy discloses new DPP IV/ACE inhibitors

Aug. 19, 2011

FDA accepts for review Protalix Biotherapeutics' resubmitted NDA for taliglucerase alfa

Aug. 18, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...